PFE, BMY Yields Compared in Motley Fool Dividend Piece
What happened
The Motley Fool published a side-by-side analysis on June 4 comparing Pfizer (PFE) and Bristol Myers Squibb (BMY) as high-yield dividend options within large-cap pharma. Both companies carry dividend yields elevated relative to the broader S&P 500. Pfizer shares closed at $25.72 on the session, reflecting a stock price that has remained under multi-year pressure and consequently pushed its yield into high-yield territory. The piece carried a neutral sentiment score, reflecting no clear editorial preference for either name.
The QL Read
QuantLogix composite for PFE sits at 44/100 (Neutral), suggesting no decisive factor tilt currently behind the name. The +1.60% session move is worth noting in context: any sustained move higher from the $25.72 level would mechanically reduce the forward yield that anchors the comparison.